Galectin Therapeutics Inc
GALT
$3.67-1.08%
Delayed · as of Oct 16, 2026, 2:00 PM ET
Mkt cap
$142.41M
EV/Sales
N/A
P/E ratio
N/A
Revenue (FY2025)
N/A
EPS (H1 2026)
$-0.22
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
0.55
Div yield
N/A
Sector
Healthcare
Galectin Therapeutics Inc (GALT) is a biotechnology company listed on US.
Use this GALT research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full GALT income, balance, and cash tables.
Galectin Therapeutics Inc (GALT) is a biotechnology company in the Healthcare sector.
Latest cached Galectin Therapeutics Inc (GALT) net income for FY2025 was -$30.8M. Statements: https://lician.com/financials/galt
Galectin Therapeutics Inc (GALT) market capitalization is $142.4M on the latest cached snapshot.
Galectin Therapeutics Inc (GALT) cached previous close $3.71; day range $3.67 – $3.71; volume 95,071. Session quote: https://lician.com/quote/galt
Galectin Therapeutics Inc (GALT) latest cached earnings event is "GALT earnings" on Aug 14, 2026. Earnings calendar: https://lician.com/earnings
The latest cached GALT filing is 8-K · Aug 14, 2026. Filings: https://lician.com/sec/galt